Ridley Scott is set to launch his first science‑fiction film since 2017’s *Alien: Covenant* with the dystopian adventure *The Dog Stars*, slated for a global release on August 28 . The move follows the under‑performance of his recent historical epics *Napoleon* and *Gladiator II*, which failed to hit their projected profit thresholds despite hefty budgets and star‑studded casts.

The $200 million gamble on *Napoleon* fell short

*Napoleon* earned roughly $222 million worldwide, according to box‑office repports, but that figure left the film well below the estimated $300 million needed to break even after accounting for marketing and distribution costs. The shortfall was compounded by criticism over the film’s historical liberties,which may have dampened audience enthusiasm.

*Gladiator II* missed its $500 million target despite a $250 million budget

Even with a $460 million global haul, *Gladiator II* did not reach the $500 million benchmark set by studio executives.. The sequel’s absence of original lead Russell Crowe and mixed critical reception were cited as factors, according to industry analysts.

August 28 release positions *The Dog Stars* as a summer tentpole

The new film’s launch date follows a delayed March premiere, a shift that has amplified anticipation among fans. The first trailer, which has already amassed millions of views online, showcases a bleak, visually striking world that aligns with current audience appetite for dystopian narratives.

Star‑power lineup: Jacob Elordi, Josh Brolin and Margaret Qualley

Scott has assembled a high‑profile cast, pairing *Euphoria* star Jacob Elordi with *Sicario* veteran Josh Brolin and *Once Upon a Time… in Hollywood* alum Margaret Qualley. Their involvement is expected to draw younger demographics while retaining the director’s traditional fan base.

Open question:Will sci‑fi redemption offset historical setbacks?

Analysts are still unsure whether *The Dog Stars* can generate the $500 million worldwide gross needed to fully recover from the recent losses . The film’s performance will also test whether Scott’s return to sci‑fi after a six‑year hiatus can reignite the commercial momentum that once defined his career.